References
- Cawley JC, Burns GF, Hayhao FGJ. A chronic lymphopro-liferative disorder with distinctive features: a distinct variant of hairy cell leukaemia. Leuk Res 1980;4:547–559.
- Foucar K, Catovsky D. Hairy cell leukaemia. WHO classifica-tion of haemopoietic and lymphoid tumours. Lyon: IARC Press; 2001. p 138–141.
- Matutes E, Wotherspoon A, Catovsky D. The variant form of hairy-cell leukaemia. Best Prac Res Clin Haemat 2003;16:41 — 56.
- Sainati L, Matutes E, Mulligan S, de Oliveira MP, Rau S, Lampert IA, et al. A variant form of hairy cell leukaemia resistant to alfa-interferon: clinical and phenotypic character-istics of 17 patients. Blood 1990;76: 157 —162.
- Matutes E, Wotherspoon A, Brito-Babapulle V, Catovsky D, et al. The natural history and clinico-pathological features of the variant form of hairy cell leukaemia. Leukaemia 2001;15:184–186.
- Robak T, Blasinska-Morawiec M, Blonski J, Hellmann A, Halaburda K, Konopka L, et al. 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukaemia and hairy cell leukaemia variant: 7 year experience in Poland. Eur J Haematol 1999;62:49— 56.
- Goodman G, Bethel K, Saven A. Hairy cell leukaemia — an update. Curr Opin Haematol 2003;10:258–266.
- Kreitman RJ, Wilson WH, Bergeron K, Raggio M, Stetler-Stevenson M, Fitzgerald DJ, et al. Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy cell leukaemia. N Engl J Med 2001;345: 241–247.
- Hagberg G, Lundholm L. Rituximab, a chimeric anti-CD20 monoclonal antibody, in the treatment of hairy cell leukaemia. Br J Haematol 2001;115:609 — 611.
- Lauria F, L,enoci M, Annino L. Efficacy of anti-CD20 antibodies (Mabthera) in patients with progressed hairy cell leukaemia. Haematologica 2001;86: 1046— 1050.
- Thomas D, O'Brien S, Beuso-Ramos C. Rituximab in relapsed or refractory hairy cell leukaemia. Blood 2003;102:3906–3911.
- Nieva J, Bethel K, Saven K. Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemia. Blood 2003;102: 810 — 813.
- Seymour J, Kurzrock R, Freireich EJ, Estey EH. 2-Chloro-deoxyadenosine induces durable remissions and prolonged suppression of CD4 + lymphocyte counts in patients with hairy cell leukaemia. Blood 1994;83:2906–2911.